Vanda Pharmaceuticals Inc. filed suit against the US FDA to get the agency to revoke the partial clinical hold it imposed on its gastoparesis drug candidate tradipitant. But it is also using the complaint to campaign against FDA's animal research policy, saying it results in the unnecessary killing of dogs and other animals.
The company issued an open letter to FDA the day it filed the Feb. 5 complaint, in which...





